TCA antidepressant update
This video discusses the misconceptions about the side effects and risks of TCAs and explains that the differences between them and newer drugs are much smaller than is generally supposed. Coupled with the fact that amitriptyline and clomipramine are almost certainly more potent antidepressants for melancholic-type depression than any of the newer drugs, this should influence practitioners to use them more frequently and sooner in the treatment algorithm. The material on my PsychoTropical website gives detailed justification and references for the points discussed. [more and updated links coming soon] Also see • Most Medical Research is Flawed... w/ Ken ... where I discuss similar themes with Dr Short on his podcast

▶︎
Nardil - What does Dr Ken Gillman really think about Nardil?

▶︎
Find out why YOU need dopamine and why MAOIs are essential

▶︎
Patients Guide to Adjusting Parnate

▶︎
TCAs: An Introduction

▶︎
SSRIs Are The Scam of the Century - Doctor Reacts To Matt Walsh

▶︎
Recovering on your own

▶︎
MAOI Clinical Case with Dr. Ken Gillman

▶︎
First 20 Days on Anti-Depressants, 50mg | Sertraline Journey | Side Effects

▶︎
Tricyclic Antidepressants: Are They Really Better Than SNRIs?

▶︎
Depression - What is it?

▶︎
Something is jamming GPS over Europe. Here's what we found

▶︎
Other MAOIs - Moclobemide, Selegiline, Rasagiline

▶︎
Tyramine for Doctors

▶︎
Tricyclic Antidepressants (TCA): Pharmacology Made Easy & Relevant

▶︎
8.7 MILLION Brits on Antidepressants…And We Might Be Getting It WRONG | Dr Joanna Moncrieff Part 2

▶︎
Duloxetine Withdrawal | Brain Zaps | Withdrawal Advice | SOPHIE SEGER

▶︎
Dr. Gillman answers your questions - Facebook Q&A!

▶︎
When Tricyclic Antidepressants May Be Your Better Option

▶︎
Beta Blockers and MAOIs

▶︎
